Enzon Pharmaceuticals Inc (ENZN)
0.0795
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Enzon Pharmaceuticals Market Cap: 5.900M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 5.900M |
| November 12, 2024 | 5.863M |
| November 11, 2024 | 6.281M |
| November 08, 2024 | 6.308M |
| November 07, 2024 | 6.308M |
| November 06, 2024 | 6.308M |
| November 05, 2024 | 6.664M |
| November 04, 2024 | 5.844M |
| November 01, 2024 | 6.123M |
| October 31, 2024 | 6.679M |
| October 30, 2024 | 5.714M |
| October 29, 2024 | 6.679M |
| October 28, 2024 | 5.937M |
| October 25, 2024 | 7.429M |
| October 24, 2024 | 7.792M |
| October 23, 2024 | 7.792M |
| October 22, 2024 | 8.089M |
| October 21, 2024 | 9.269M |
| October 18, 2024 | 9.269M |
| October 17, 2024 | 8.701M |
| October 16, 2024 | 8.701M |
| October 15, 2024 | 8.701M |
| October 14, 2024 | 8.164M |
| October 11, 2024 | 8.599M |
| October 10, 2024 | 8.175M |
| Date | Value |
|---|---|
| October 09, 2024 | 8.639M |
| October 08, 2024 | 8.171M |
| October 07, 2024 | 9.626M |
| October 04, 2024 | 8.164M |
| October 03, 2024 | 10.38M |
| October 02, 2024 | 8.535M |
| October 01, 2024 | 8.891M |
| September 30, 2024 | 10.39M |
| September 27, 2024 | 8.906M |
| September 26, 2024 | 8.98M |
| September 25, 2024 | 8.98M |
| September 24, 2024 | 11.03M |
| September 23, 2024 | 9.054M |
| September 20, 2024 | 10.45M |
| September 19, 2024 | 10.45M |
| September 18, 2024 | 9.819M |
| September 17, 2024 | 10.02M |
| September 16, 2024 | 8.906M |
| September 13, 2024 | 9.356M |
| September 12, 2024 | 9.388M |
| September 11, 2024 | 9.284M |
| September 10, 2024 | 9.863M |
| September 09, 2024 | 10.39M |
| September 06, 2024 | 11.13M |
| September 05, 2024 | 11.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.453M
Minimum
Mar 19 2024
61.97M
Maximum
Feb 08 2021
18.32M
Average
14.12M
Median
Jun 26 2023
Market Cap Benchmarks
| AIM ImmunoTech Inc | 15.58M |
| Perspective Therapeutics Inc | 625.05M |
| Protalix BioTherapeutics Inc | 101.49M |
| Electromed Inc | 252.26M |
| Armata Pharmaceuticals Inc | 98.78M |
Market Cap Related Metrics
| PE Ratio | 60.73 |
| Price to Book Value | 2.136 |
| Price to Free Cash Flow | 4.367 |
| Price | 0.0795 |
| Earnings Yield | 1.65% |
| Normalized PE Ratio | 35.96 |